International Reference Pricing and Biosimilars

Author(s)

Steffen Wahler, MD; MA, St. Bernward GmbH, Hamburg, Germany

Beyond HTA and negotiations there are other measures to influence pricing of pharmaceuticals: International reference pricing and the topic of biosimilars.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

234

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×